Transform scattered market data into systematic launch advantage with intelligence-powered strategy frameworks
Curated pharmaceutical data
Access comprehensive pharmaceutical pricing intelligence
Make confident pricing decisions with validated data from 100+ markets. Our proprietary datasets combine list prices, net pricing, rebates, and market access outcomes, including regulatory intelligence for IRA, MFN, and JCA requirements, that you won’t find anywhere else.
Enabled by technology
Turn weeks of analysis into actionable insights in minutes
Our AI-powered platform combines real-time market intelligence with predictive analytics and scenario modelling. Get instant IRP simulations, competitive tracking, and automated reporting tailored to your workflow.
Guided by specialist pricing and market access expertise
Navigate complex pricing and market access challenges with the support of proven pharmaceutical pricing experts
Our senior consultants have guided successful launches across HTA-led, IRP-driven, and hybrid markets. From early-stage valuation to lifecycle management, we turn pricing complexity into competitive advantage.
We are the global pharmaceutical pricing specialists.
Our curated data, enabled by technology and guided by specialist expertise, delivers your pharmaceutical market advantage.
Global pharmaceuticals trust
Global Pricing Innovations
Global Pricing Innovations
Transform your pricing & market access strategy
Unified intelligence for pharmaceutical excellence
Trusted by leading pharmaceutical companies worldwide
Navigate
by the challenges you face
Data fragmentation
Disparate data sources hinder a unified view of market access and pricing insights.
Resource constraints
Manual data collection and analysis consume valuable time, delaying strategic decisions.
Designed
for how you work
Global & Executive
Leadership
Global oversight, IRP governance, launch sequencing, enterprise-wide policy compliance.
Regional & Functional
Leads
Regional alignment, HTA strategies, budget impact, coordination across markets.
Local & Affiliate
Teams
Local data accuracy, contracting & tender intelligence, submission support workflows.
Technical & Integration
Teams
Data infrastructure and automation for pricing and market access systems.
Answer 3 questions to get a solution recommendation
Curated data, enabled by technology, guided by specialist expertise.
Technology enabled
Intuitive digital interface with real-time insights, AI-powered analytics and visual dashboards
Specialist expertise
Senior pricing experts guiding decisions across the lifecycle with integrated support
Driving pharmaceutical excellence
Meet our leaders
Our success stems from a seasoned professional team bringing extensive experience and expertise to every client engagement.
Wayne Speechly
CEO
Preeti Patel
Founder & Board Advisor
Our services
We're on the
Pulse of industry
trends
Expert team
Senior pharmaceutical pricing specialists with deep market access expertise across global markets, guiding major pharma companies through complex regulatory and competitive landscapes.
Innovative approach
Leveraging cutting-edge technology, data and methodologies to solve complex pharmaceutical pricing and market access challenges with AI-powered insights and predictive analytics.
Our team collectively brings decades of experience across every discipline.
+170 years
Market Access
+200 years
Pharmaceutical
+250 years
Data & Analytics
Proven results
Trusted by leading pharmaceutical companies including Pfizer, AstraZeneca, and Novo Nordisk to accelerate market advantage, optimise launch strategies, and drive measurable ROI.
Why us
GPI delivers
data excellence
transformative insights
specialist pricing expertise
Purpose-built for pharmaceutical pricing and market access teams
Testimonials
Why our clients love working with us
Pfizer inc.
GPI is always ready to listen, flexible, available and amenable to all business needs. Pfizer relies heavily on GPI’s Cost of Treatment calculations in order to determine which products we have to report on, and therefore upholding our reputation.
Michelle Pardo, Pricing Manager, Pfizer Inc.
Fortrea
My experience with GPI is overall very good. GPI Pulse provides detailed information about pricing and reimbursement landscape… In studies where we need to classify countries based on reimbursement status, GPI is an essential source.
Global Feasibility Lead, Fortrea
LFB
Major impact. As GPI is our only price database provider, we fully trust them… We’ve been working together for a while and GPI has always met our expectations and solved our problems if any.
Marc Gauthier-Darnis, Global Market Access Director & Director of Corporate Affairs LFB
Our blog
Insights & strategies. Your guide to smarter Pricing and Market Access.
Transform scattered market data into systematic launch advantage with intelligence-powered
A solution to challenges associated with the fragmented USA payersystem
Curated by our expert team
Helpful downloads to simplify your challenges
The 5-step clinical trial feasibility intelligence framework
Transform weeks of manual research into hours of strategic analysis with platform-powered treatment landscape intelligence for superior feasibility assessments.
Building winning launch strategies with market access intelligence
Transform scattered market data into systematic launch advantage with market access intelligence frameworks for pricing and market access excellence.
Navigating USA pharmaceutical pricing
Access comprehensive pharmaceutical pricing intelligence across 6 price types and 3 distinct sources to navigate the fragmented USA payer system with confidence.
Transforming launch strategy:A 5-step intelligence framework
GPI’s USA pricing data
A solution to challenges associated with the fragmented USA payer
system for market access and pricing decisions.
Transforming clinical feasibility: A 5-step intelligence framework
Transform weeks of manual research into hours of strategic
analysis with platform-powered intelligence
